Boston Scientific(US:BSX) Businesswire·2026-03-06 16:42Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of Boston Scientific Corporation stockholders, alleging that the company misled investors regarding its business operations, particularly in the U.S. Electrophysiology segment, leading to a net income miss and disappointing guidance for the first half of fiscal 2026 [1]. Group 1: Allegations and Lawsuit Details - The class action lawsuit covers stock purchases made between July 23, 2025, and February 3, 2026 [1]. - The lawsuit claims that Boston Scientific's management was aware that the growth rate of its U.S. Electrophysiology segment was unsustainable, yet continued to make positive statements to investors [1]. - Investors were reportedly surprised by the company's net income miss and underwhelming guidance due to the misleading statements made by the defendants [1]. Group 2: Participation and Representation - Shareholders interested in serving as lead plaintiffs must file motions with the court by May 4, 2026 [1]. - Participation in the lawsuit is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [1]. - Rosen Law Firm operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless they recover losses [1].